sulfamethoxazole has been researched along with Gram-Negative Bacterial Infections in 7 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Zhao, H | 1 |
Wang, Y | 1 |
Guo, M | 1 |
Mu, M | 1 |
Yu, H | 1 |
Xing, M | 1 |
Herrera-Heredia, SA | 1 |
Pezina-Cantú, C | 1 |
Garza-González, E | 1 |
Bocanegra-Ibarias, P | 1 |
Mendoza-Olazarán, S | 1 |
Morfín-Otero, R | 1 |
Camacho-Ortiz, A | 1 |
Villarreal-Treviño, L | 1 |
Rodríguez-Noriega, E | 1 |
Paláu-Davila, L | 1 |
Maldonado-Garza, HJ | 1 |
Flores-Treviño, S | 1 |
Watson, L | 1 |
Esterly, J | 1 |
Jensen, AO | 1 |
Postelnick, M | 1 |
Aguirre, A | 1 |
McLaughlin, M | 1 |
Livermore, DM | 1 |
Mushtaq, S | 1 |
Warner, M | 1 |
Woodford, N | 1 |
Estrada, A | 1 |
Wright, DL | 1 |
Anderson, AC | 1 |
Al-Jasser, AM | 1 |
Rosini, JM | 1 |
Martinez, E | 1 |
Jain, R | 1 |
1 review available for sulfamethoxazole and Gram-Negative Bacterial Infections
Article | Year |
---|---|
Antibacterial Antifolates: From Development through Resistance to the Next Generation.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Folic Acid Antagonists; Gram-Negative Bacterial I | 2016 |
6 other studies available for sulfamethoxazole and Gram-Negative Bacterial Infections
Article | Year |
---|---|
Grass carps co-exposed to environmentally relevant concentrations of cypermethrin and sulfamethoxazole bear immunodeficiency and are vulnerable to subsequent Aeromonas hydrophila infection.
Topics: Aeromonas hydrophila; Animal Feed; Animals; Carps; Diet; Ecosystem; Fish Diseases; Fish Proteins; Gr | 2020 |
Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacter | 2017 |
Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Female; Fluoroquinolones; | 2018 |
Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacter | 2014 |
Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.
Topics: Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; | 2006 |
Severe hypoglycemia associated with use of trimethoprim/sulfamethoxazole in a patient with chronic renal insufficiency.
Topics: Aged; Anti-Bacterial Agents; Drug Combinations; Endophthalmitis; Gram-Negative Bacterial Infections; | 2008 |